Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results

Table 4 Analysis of Banff score changes in PE-IVIG-RTX group

	Pre PE-IVIG-RTX (n = 9)	Post PE-IVIG-RTX (n = 8)	P-value
Chronic glomerulopathy (cg)	2 (1-3)	2 (1-3)	0.705
Glomerulitis (g)	2 (1-3)	0.5 (0-2)	0.054
Peritubular capillaritis (ptc)	1 (0-2)	0.5 (0-2)	0.160
Microvascular inflammation (g + ptc)	3 (2-5)	1.5 (0-4)	0.047
Interstitial inflammation (ci)	1 (0-3)	1 (1-3)	0.480
Tubular atrophy (ct)	0 (0-1)	1 (0-2)	0.059
Chronicity score (ci + ct)	1 (0-3)	2 (1-5)	0.084
C4d+, n (%)	7/9 (77.8)	3/8 (37.5)	0.083
C4d score	2 (0-3)	0 (0-3)	0.102

Data are expressed as median (min-max).